Over 20 years of successful track record in biotech start-up, drug R&D, and business development.
Founding member of Hutchison Medipharma (Shanghai). Served as Senior Director of Medicinal Chemistry and Executive Director of IP, and contributed to the clinical development of two drugs in the US. Later served as Executive Director of the Business Development department and successfully established strategic partnership with Procter & Gamble, MSD Germany, and Eli Lilly and Company. In 2006, served as core member of the IPO team in successfully raising 40 million pounds in the UK stock market.
Senior Scientist at Johnson & Johnson and Pfizer, with one responsible drug candidate completed Phase II clinical trial in the US.
Ph.D. in bio-organic chemistry from Rutgers, the State University of New Jersey. BS in chemistry from Fudan University.